bpc 157 human clinical trial evidence safety regulatory status Here's a nice graphic on BPC-157 that you can hand out to patients who inquire about it. Thanks to Chris Centeno, M.D The Stable Gastric Pentadecapeptide BPC
Description
The Receptor Ceiling: BPC-157 functions by binding to specific receptors on your cells
Slow injection down the vial wall prevents disruption of the powder cake and avoids foaming that degrades the peptide
"RFK Jr.'s absurd statistic on the spike in chronic diseases in the U.S." The Washington Post
Each order of GLP-1 Microdose includes three 1mL vials of GLP-1 and, if clinically appropriate, an additive (B-12, Glycine, or L-Carnitine)
